Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > imagine the questions a big investor would ask..

<< Previous

Bullboard Posts

Next >>

Comment by Tarbabyon Jul 15, 2024 11:54am

175 Views

Post# 36133033

RE:RE:RE:RE:imagine the questions a big investor would ask..

Just one of their new discoveries might have an easy path...this is that Rudivar can potentiate BCG to be much more effective..
Since it is already approved to be instilled into bladders why not just add it to BCG in a quick low cost trial by a willing urologist and patient. With Health Canada approval of course..

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023